United States · FDA National Drug Code directory
LECANEMAB AUTOINJECTOR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62856-222_5bf59fb4-34d6-40dd-9061-a74173f14f58
- Product NDC
- 62856-222
- Form
- INJECTION, SOLUTION
- Composition / generic term
- lecanemab-irmb
- Labeler
- Eisai Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20260713
- Source listing expiry
- 20271231
Source-listed ingredients
- LECANEMAB-IRMB — 200 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 SYRINGE, PLASTIC in 1 CARTON (62856-222-02) / 1.25 mL in 1 SYRINGE, PLASTIC (62856-222-10) · 62856-222-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →